With nitroglycerin or organic nitrates
Safety flag
Systemic acetylcysteine can potentiate nitrate-related vasodilation, headache, and hypotension.
Interaction evidence source All research profiles
Antioxidant / mucolytic
Acetylcysteine
Prepared by the ezGLP team. Sources last checked .
Also known as N-acetylcysteine, NAC
Routes represented in the knowledgebase: Oral / Inhaled / Other / unspecified.
Educational overview
Prescription forms have specific toxicology and respiratory indications; general antioxidant and recovery uses are off-label or supplement uses.
- Category
- Antioxidant / mucolytic
- Routes represented
- Oral / Inhaled / Other / unspecified
- Storage context
- Follow the product or pharmacy label; requirements vary by route and formulation.
Published literature
No validated PubMed or DOI link is currently curated for this entry.
Safety evidence
Common or reported: rash, flushing, itching, nausea.
Serious or important: anaphylaxis, hypotension, wheezing or bronchospasm, fluid overload with IV use.
IV risks should not be generalized to ordinary oral supplement use.
Safety evidence sourceInteraction evidence
These are general, pairwise evidence notes. Green identifies the potential-synergy category, while Lv3/Lv2/Lv1 communicates evidence strength; it does not guarantee benefit or cancel a safety warning.
With glutathione
Complementary evidenceLv3
A small clinical study in early septic shock reported lower lipid-peroxidation markers and improved clinical scores when acetylcysteine was added to glutathione.
Interaction evidence sourceRelated clinical studyFDA sterile-glutathione warningSummarised from published literature for reference only, with citations to the source. Evidence is graded as reported and is not a recommendation to combine, dose, or use any compound.
For personal tracking and education only. Not medical advice, diagnosis, or treatment, and not a medical device. Peptides may be prescription-only or unapproved where you live — consult a licensed healthcare professional.